Sep 2026· Exploration of Cardiology· 0 citations· 13 references
TL;DR
A case series of three patients who developed overt DIC while receiving veno-arterial or veno-venous ECMO at a tertiary academic medical center between 2023 and 2025 is presented, highlighting the importance of vigilance for early indicators of impending DIC, including thrombus formation within the ECMO oxygenator or circuit.
Abstract
Extracorporeal membrane oxygenation (ECMO) is a life-saving intervention for patients with refractory cardiac or respiratory failure. Complications associated with ECMO include bleeding, thrombosis, and coagulopathy. Overt disseminated intravascular coagulation (DIC) in ECMO patients is a rare but severe complication, yet its presentation, timing, and outcomes remain poorly portrayed in the literature. We present a case series of three patients who developed overt DIC while receiving veno-arterial (V-A ECMO) or veno-venous (V-V ECMO) at a tertiary academic medical center between 2023 and 2025. Overt DIC was diagnosed using the International Society on Thrombosis and Haemostasis (ISTH) scoring system, with scores ≥ 5 considered diagnostic. All patients met the ISTH criteria for overt DIC during ECMO support upon case review. Laboratory findings demonstrated severe thrombocytopenia, prolonged prothrombin time (PT)/international normalized ratio (INR), and hypofibrinogenemia. Despite supportive management, including blood product replacement, targeted anticoagulation adjustments, and correction of underlying triggers, overall, 2 out of 3 patients in the series died during their index hospital admissions. Overt DIC during ECMO is a life-threatening complication associated with risk of bleeding and poor prognosis. These cases emphasize the importance of vigilance for early indicators of impending DIC, including thrombus formation within the ECMO oxygenator or circuit. Once identified, a timely oxygenator exchange may improve circuit performance and oxygenation, potentially limiting further activation of the coagulation cascade. Urgent decannulation should be considered when extracorporeal support is no longer essential for survival. In conclusion, these cases highlight the importance of early recognition and multidisciplinary management of ECMO-associated DIC and support the need for further research to develop strong evidence-based strategies for prevention and treatment.
Objective: This study aimed to evaluate the use of bivalirudin as an alternative to conventional anticoagulant therapy with heparin in patients requiring venovenous extracorporeal membrane oxygenation (V-V ECMO) support for Acute Respiratory Distress Syndrome (ARDS), with a focus on dose titration, therapeutic range mo...
Özge Kuzgun, Kezban Özmen Süner, Fatih Toptan et al.· Turkish Journal of Intensive...· 0 citations
Extracorporeal membrane oxygenation (ECMO) has a life-saving role in trauma management, with particular relevance to patients with acute respiratory failure. This narrative review describes the current evidence on the use of ECMO in the resuscitation of major trauma victims presenting with acute respiratory distress sy...
Canan Akman, Asli Bahar Uçar, Gökhan Yılmaz et al.· Scottish Medical Journal· 0 citations
High-risk pulmonary embolism (PE) with severe thrombocytopenia creates competing reperfusion and bleeding risks. A 28-year-old man presented with obstructive shock and central pulmonary arterial filling defects. The last documented platelet count before alteplase was 21 × 10⁹/L; platelet transfusion intervened, and the...
Le Kang, Yan-Fei Lin, Shuai Wang et al.· Frontiers in Cardiovascular...· 0 citations
The combination of ECMO with catheter‐directed thromboaspiration proved effective in restoring hemodynamic stability and resolving thrombotic obstruction, offering a viable rescue strategy in life‐threatening postpartum PE.
F. Varón-Vega, M. C. Martínez-Ayala, Eduardo Tuta-Quintero et al.· Case Reports in Obstetrics a...· 0 citations
Mechanical circulatory support in sickle cell anemia patients undergoing complex cardiovascular surgery remains a subject of controversy. This is due to the risk of vaso-occlusive and prothrombotic phenomena associated with hypoxia, acidosis, inflammation, and contact with non-endothelialized surfaces. However, veno ar...
Juan Carlos Kling, Paula Santamaria, María Angélica Echeverry Castaño et al.· The Journal of ExtraCorporea...· 0 citations
This work shows that even severe bleeding in the airway can be handled safely, and you don’t have to stop anticoagulation treatment to do it, and the patient was able to come off ECMO successfully after 73 hours of use.
Kun Cao, Hai Feng· Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.